Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ryoko Ishiyama"'
Autor:
Naoteru Miyata, Katsura Emoto, Yoshiaki Dei, Kazuhiro Tomiyasu, Ryoko Ishiyama, Tomofumi Horie, Gen Sakai, Toshiyuki Tahara
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 547-553 (2016)
Background: Dermatomyositis (DM) is an autoimmune disease characterized by cutaneous Gottron papules, heliotrope rash, and proximal myopathy. It may also present as a paraneoplastic syndrome that can complicate a variety of different cancers, such as
Externí odkaz:
https://doaj.org/article/f440340dcdd341599f2d75d370f03be5
Autor:
Toshiyuki Tahara, Kazuhiro Tomiyasu, Naoteru Miyata, Gen Sakai, Yoshiaki Dei, Katsura Emoto, Tomofumi Horie, Ryoko Ishiyama
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 547-553 (2016)
Case Reports in Oncology
Case Reports in Oncology
Background: Dermatomyositis (DM) is an autoimmune disease characterized by cutaneous Gottron papules, heliotrope rash, and proximal myopathy. It may also present as a paraneoplastic syndrome that can complicate a variety of different cancers, such as
Autor:
Kiyoto Mori, Satoshi Shinozaki, Mari Mochizuki, Marin Noda, Hitomi Hoshi, Ryoko Ishiyama, Toshiyuki Tahara, Alan Kawarai Lefor
The treatment of refractory ascites due to cirrhosis is a clinical challenge for hepatologists. Tolvaptan, a novel aquaporin modulator, was made available in Japan in 2013 for the treatment of patients with refractory ascites due to cirrhosis. Despit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6d1e06ed58d2df84936b9f99b328eb7
https://europepmc.org/articles/PMC5727763/
https://europepmc.org/articles/PMC5727763/
Autor:
TOSHIYUKI TAHARA, KIYOTO MORI, MARI MOCHIZUKI, RYOKO ISHIYAMA, MARIN NODA, HITOMI HOSHI, KAWARAILEFOR, ALAN, SATOSHI SHINOZAKI
Publikováno v:
Biomedical Reports; Dec2017, Vol. 7 Issue 6, p558-562, 5p